Sat, Aug 2, 2014, 5:53 AM EDT - U.S. Markets closed


% | $
Click the to save as a favorite.

Neurocrine Biosciences Inc. Message Board

you are viewing a single comment's thread.

view the rest of the posts
  • nowwheretogo22004 nowwheretogo22004 Apr 13, 2012 9:41 AM Flag


    March 27th press release "Elagolix Endometriosis Phase III Trials on Track to Commence in Second Quarter 2012" Ya, that sounds like Abbott is pulling out of this!

    Actually, stick to your one liners. It's better to be thought of as stupid than to open your mouth and remove all doubt.

    For the rest of you, I'm not saying that everything is guaranteed to come up roses. I'm just saying that there is a lot of potential here, more than most other biotechs. Until there is more news announced, this stock will continue to swing wildly. I think it's best to buy a little of it and not stare at it every day. A year from now, those who hang on will likely be well rewarded.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • We will see - here's your one-liner :)
      In the meantime, the pps never lies, here's your $7.30-ish (and dropping)

      Even if the trial goes on, it will likely fail miserably and Neurocrine will be at $2 where it really belongs.
      Endometriosis already has a certain laparoscopic procedure which is harmless... Yes, invasive but harmless.

13.46-0.12(-0.88%)Aug 1 3:59 PMEDT

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.